Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS FINAL EXAM 2026/2027 | Complete Study Guide | 100% Correct Verified Answers | Pass Guaranteed - A+ Graded

Beoordeling
-
Verkocht
-
Pagina's
42
Cijfer
A+
Geüpload op
28-05-2026
Geschreven in
2025/2026

Pass the WGU D027 Advanced Pathopharmacological Foundations Final Exam on your first attempt with this complete 2026/2027 study guide featuring 100% correct verified answers. This A+ Graded resource is a comprehensive final exam study guide containing 100% correct verified answers covering every advanced pathopharmacology domain required for final exam mastery. Section 1: Foundational Pathophysiology – cellular adaptation, injury, necrosis, apoptosis, inflammation and immune response mechanisms, genetics and genomics in disease, neoplasia and cancer biology, fluid and electrolyte imbalances, acid-base disorders and compensation mechanisms. Section 2: Foundational Pharmacology – pharmacokinetics (absorption, distribution, metabolism, excretion), pharmacodynamics (receptor theory, dose-response curves, therapeutic index, potency, efficacy), adverse drug reactions and medication safety, drug-drug and drug-food interactions, polypharmacy risks, pharmacogenomics and genetic variations, personalized medicine applications. Section 3: Cardiovascular System – hypertension pathology and antihypertensive drug classes (ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, diuretics), heart failure pathophysiology and treatment guidelines (digoxin, diuretics, beta-blockers, ACE inhibitors, ARNI), coronary artery disease and antianginal agents (nitrates, beta-blockers, calcium channel blockers), dyslipidemias and lipid-lowering medications (statins, fibrates, niacin, ezetimibe, PCSK9 inhibitors), arrhythmias and antiarrhythmic drug classifications (Class I-IV). Section 4: Respiratory System – COPD pathology and pharmacotherapy (bronchodilators, corticosteroids, roflumilast), asthma pathophysiology and stepwise pharmacotherapy (SABA, LABA, ICS, leukotriene modifiers, monoclonal antibodies), pulmonary hypertension treatments. Section 5: Renal and Urinary System – acute kidney injury and chronic kidney disease pathophysiology, drug dosing adjustments based on GFR, diuretic classifications and mechanisms, glomerulonephritis and pharmacotherapy. Section 6: Gastrointestinal System – GERD, PUD, IBD (Crohn's, UC), cirrhosis, pancreatitis – pathophysiology and medication management (PPIs, H2 blockers, antacids, 5-ASA, immunomodulators, biologics). Section 7: Endocrine System – diabetes mellitus Type 1 and Type 2 pathophysiology, insulin preparations (rapid, short, intermediate, long-acting), oral hypoglycemics (metformin, sulfonylureas, TZDs, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 agonists), thyroid disorders (hypothyroidism: levothyroxine; hyperthyroidism: methimazole, PTU), adrenal disorders (corticosteroid therapy). Section 8: Neurologic System – stroke pathophysiology and acute management (tPA, antiplatelets), seizure disorders and anticonvulsant drugs (phenytoin, valproate, levetiracetam, lamotrigine), Parkinson's disease and dopaminergic agents (levodopa/carbidopa, dopamine agonists), Alzheimer's disease (cholinesterase inhibitors, memantine), multiple sclerosis disease-modifying therapies. Section 9: Psychiatric Disorders – depression and antidepressant classes (SSRIs, SNRIs, MAOIs, TCAs, atypical antidepressants), anxiety disorders and anxiolytics (benzodiazepines, buspirone, SSRIs), bipolar disorder and mood stabilizers (lithium, valproate, lamotrigine, carbamazepine), schizophrenia and antipsychotic agents (typical first-generation, atypical second-generation). Section 10: Hematologic System – anemias and treatments (iron, B12, folate, erythropoietin), coagulopathies and anticoagulant/antiplatelet therapies (warfarin, heparin, DOACs, aspirin, clopidogrel), thrombosis pathophysiology. Section 11: Immunologic System – autoimmune disease pathogenesis, immunosuppressants (corticosteroids, calcineurin inhibitors, antimetabolites, biologics), hypersensitivity reactions, immunodeficiencies. Section 12: Musculoskeletal System – osteoporosis pharmacotherapy (bisphosphonates, denosumab, teriparatide, raloxifene), osteoarthritis treatment (acetaminophen, NSAIDs, intra-articular injections), rheumatoid arthritis (DMARDs: methotrexate, biologics, JAK inhibitors), gout management (colchicine, NSAIDs, allopurinol, febuxostat). Section 13: Infectious Diseases – antimicrobial therapies: antibiotics by mechanism/class (penicillins, cephalosporins, macrolides, tetracyclines, aminoglycosides, fluoroquinolones, sulfonamides), antivirals, antifungals, antiparasitics, antimicrobial resistance principles and stewardship. Section 14: Special Populations – pediatric pharmacokinetic/pharmacodynamic considerations, geriatric pharmacotherapy challenges, pregnancy/lactation medication safety, hepatic impairment drug adjustments, renal impairment drug dosing. Each answer includes detailed pathophysiological and pharmacological rationales to reinforce clinical reasoning for final exam success. Perfect for advanced practice nursing students and graduate-level learners. With our Pass Guarantee, you can confidently pass your WGU D027 Final Exam. Download your complete WGU D027 Final Exam Study Guide instantly!

Meer zien Lees minder
Instelling
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS
Vak
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS

Voorbeeld van de inhoud

1



WGU D027 ADVANCED PATHOPHARMACOLOGICAL
FOUNDATIONS FINAL EXAM 2026/2027 | Complete Study
Guide | 100% Correct Verified Answers | Pass Guaranteed -
A+ Graded


[Section 1: Cellular Pathophysiology, Genetics & Epigenetics (Q1-10)]

Q1. A 68-year-old patient presents with crushing chest pain and is found to have an
acute ST-elevation myocardial infarction. Within hours, the affected myocardial tissue
shows preserved tissue architecture with loss of nuclei and eosinophilic cytoplasm.
Which pattern of necrosis is described?

A. Liquefactive necrosis
B. Caseous necrosis
C. Coagulative necrosis
D. Fat necrosis

Correct Answer: C Rationale: C. Coagulative necrosis [CORRECT] — Coagulative
necrosis is characteristic of ischemic injury in solid organs with high protein content
(heart, kidney, spleen) where tissue architecture is preserved initially due to
denaturation of structural proteins. Liquefactive necrosis occurs in the brain and
abscesses, caseous necrosis is seen in tuberculosis, and fat necrosis is associated with
pancreatic enzyme release.

Q2. A patient with sepsis develops widespread cell death characterized by cell
swelling, plasma membrane rupture, and release of intracellular contents that trigger
intense inflammation. Which cell death mechanism is most likely involved?

A. Apoptosis
B. Pyroptosis
C. Autophagy
D. Necroptosis

Correct Answer: D Rationale: D. Necroptosis [CORRECT] — Necroptosis is a
regulated form of necrotic cell death mediated by RIPK1/RIPK3 and MLKL that results
in membrane rupture and inflammatory cytokine release, commonly seen in sepsis,
ischemia-reperfusion, and viral infections. Apoptosis is non-inflammatory, pyroptosis

,2



involves caspase-1 and inflammasomes (IL-1β/IL-18 release), and autophagy is
primarily a survival mechanism.

Q3. A 25-year-old man is diagnosed with Huntington's disease. His father also had
the disease, but his mother did not. Which inheritance pattern is demonstrated?

A. Autosomal recessive
B. Autosomal dominant
C. X-linked recessive
D. Mitochondrial

Correct Answer: B Rationale: B. Autosomal dominant [CORRECT] — Huntington's
disease is an autosomal dominant disorder caused by CAG trinucleotide repeat
expansion in the HTT gene on chromosome 4. Affected individuals have a 50%
chance of transmitting the mutation to each offspring. The paternal transmission
history and vertical inheritance pattern confirm autosomal dominant inheritance.

Q4. A newborn has a weak cry resembling a cat's meow, microcephaly, and severe
intellectual disability. Karyotyping reveals deletion of the short arm of chromosome
5. Which chromosomal disorder is present?

A. Cri-du-chat syndrome
B. Prader-Willi syndrome
C. Turner syndrome
D. Klinefelter syndrome

Correct Answer: A Rationale: A. Cri-du-chat syndrome [CORRECT] — Cri-du-chat
syndrome (5p deletion syndrome) is characterized by a distinctive cat-like cry,
microcephaly, severe intellectual disability, and round facies in infancy. Prader-Willi
involves 15q11.2 deletion or UPD, Turner is 45,X, and Klinefelter is 47,XXY.

Q5. A child with Prader-Willi syndrome has obesity, hypotonia, and intellectual
disability. Genetic testing shows no deletion on chromosome 15q11.2. Which
alternative mechanism explains this presentation?

A. X-linked inheritance
B. Uniparental disomy (maternal UPD 15)
C. Chromosomal translocation
D. Mitochondrial heteroplasmy

,3



Correct Answer: B Rationale: B. Uniparental disomy (maternal UPD 15) [CORRECT]
— Prader-Willi syndrome can result from paternal deletion of 15q11.2 (70%),
maternal uniparental disomy (25-30%), or imprinting defects. Maternal UPD 15
causes PWS because the paternally expressed genes on 15q11.2 are silenced on the
maternal chromosome due to genomic imprinting.

Q6. A patient with chronic myeloid leukemia has the Philadelphia chromosome,
t(9;22)(q34;q11). Which type of chromosomal abnormality is this?

A. Deletion
B. Duplication
C. Reciprocal translocation
D. Inversion

Correct Answer: C Rationale: C. Reciprocal translocation [CORRECT] — The
Philadelphia chromosome results from a reciprocal translocation between
chromosomes 9 and 22, creating the BCR-ABL fusion gene that produces a
constitutively active tyrosine kinase. This is a hallmark of CML and some cases of ALL.

Q7. A tumor suppressor gene is silenced in a cancer cell without any mutation in the
DNA sequence. Hypermethylation of CpG islands in the promoter region is identified.
Which epigenetic mechanism is responsible?

A. Histone acetylation
B. DNA methylation
C. Histone phosphorylation
D. Chromosomal translocation

Correct Answer: B Rationale: B. DNA methylation [CORRECT] — DNA methylation
at CpG islands in promoter regions is a key epigenetic mechanism of transcriptional
silencing. Hypermethylation of tumor suppressor gene promoters is a common
oncogenic event. Histone acetylation generally activates transcription, while
phosphorylation and translocation are unrelated to this specific silencing mechanism.

Q8. A microRNA (miRNA) binds to the 3' untranslated region of a target mRNA,
leading to mRNA degradation and translational repression. Which level of gene
regulation does this represent?

A. Transcriptional regulation
B. Post-transcriptional regulation

, 4



C. Translational regulation only
D. Post-translational modification

Correct Answer: B Rationale: B. Post-transcriptional regulation [CORRECT] —
miRNAs are small non-coding RNAs that regulate gene expression post-
transcriptionally by binding to complementary sequences on target mRNAs, causing
degradation or blocking translation. This occurs after transcription but before or
during protein synthesis.

Q9. A patient with cystic fibrosis has two different CFTR mutations: one common
deletion (ΔF508) and one rare missense mutation. Which term describes this genetic
state?

A. Homozygous
B. Compound heterozygous
C. Hemizygous
D. Heteroplasmy

Correct Answer: B Rationale: B. Compound heterozygous [CORRECT] — Cystic
fibrosis is autosomal recessive. A compound heterozygote has two different mutant
alleles at the same locus (e.g., ΔF508 and a rare missense mutation). Homozygous
would require identical mutations, hemizygous applies to X-linked genes in males,
and heteroplasmy refers to mixed mitochondrial DNA populations.

Q10. Inflammasome activation leads to caspase-1-mediated cleavage of pro-IL-1β
and pro-IL-18, followed by pyroptotic cell death. Which pattern recognition receptor
is most commonly associated with NLRP3 inflammasome activation?

A. TLR4
B. NOD2
C. NLRP3
D. RIG-I

Correct Answer: C Rationale: C. NLRP3 [CORRECT] — The NLRP3 inflammasome is
activated by diverse danger signals (ATP, uric acid crystals, silica, asbestos, bacterial
toxins) and leads to caspase-1 activation, IL-1β/IL-18 maturation, and gasdermin D-
mediated pyroptosis. TLR4 is a membrane-bound pattern recognition receptor,
NOD2 senses bacterial peptidoglycan, and RIG-I detects viral RNA.

[Section 2: Pharmacokinetics, Pharmacodynamics & Pharmacogenomics (Q11-18)]

Geschreven voor

Instelling
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS
Vak
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS

Documentinformatie

Geüpload op
28 mei 2026
Aantal pagina's
42
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$16.50
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF


Ook beschikbaar in voordeelbundel

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
NURSEGEDSTUDYGUIDE Chamberlain College Of Nursing
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
490
Lid sinds
3 jaar
Aantal volgers
254
Documenten
4676
Laatst verkocht
16 uur geleden
Writing and Academics (berhtonehorace at gmail dot com)

I offer a full range of online academic services aimed to students who need support with their academics. Whether you need tutoring, help with homework, paper writing, or proofreading, I am here to help you reach your academic goals. My experience spans a wide range of disciplines. I provide online sessions using the Google Workplace. If you have an interest in working with me, please contact me for a free consultation to explore your requirements and how I can help you in your academic path. I am pleased to help you achieve in your academics and attain your full potential.

Lees meer Lees minder
3.8

101 beoordelingen

5
50
4
15
3
14
2
6
1
16

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen